Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy

Xiaolei Li1,2, Wenhui Song3, Changshun Shao1

  • 1The First Affiliated Hospital of Soochow University and State Key Laboratory of Radiation Medicine and Radioprotection, Institutes for Translational Medicine, Soochow University, Suzhou, Jiangsu, 215123, China.

Insights

Predicting cancer immunotherapy success is crucial. This review covers biomarkers like gene expression and immune cell infiltration to identify patients who will benefit from checkpoint blockade therapy.

Area of Science:

  • Oncology
  • Immunology
  • Biomarker Discovery

Background:

  • Checkpoint blockade immunotherapy is a powerful cancer treatment, but its effectiveness varies significantly across cancer types and individuals.
  • Identifying patients likely to respond is essential for maximizing treatment benefits and minimizing toxicity.

Purpose of the Study:

  • To review the current landscape and advancements in predictive biomarkers for checkpoint blockade immunotherapy in cancer.
  • To highlight tools that aid in patient selection for immunotherapy and guide combination strategies.

Main Methods:

  • Review of existing literature on predictive biomarkers for cancer immunotherapy.
  • Analysis of various predictor types, including molecular and cellular markers.
  • Discussion of emerging trends and future directions in biomarker development.

Main Results:

  • Multiple predictors are emerging, focusing on checkpoint receptor ligand expression, tumor mutational burden, neoantigen and microsatellite instability, tumor-infiltrating immune cells, and peripheral blood biomarkers.
  • These predictors aim to stratify patients for immunotherapy efficacy.

Conclusions:

  • Predictive tools are vital for optimizing checkpoint blockade immunotherapy by enabling precise patient selection.
  • Continued research into novel biomarkers will enhance the efficacy and safety of cancer immunotherapy.

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
84.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Applications of GIS: Disaster Management and Emergency Response01:29

Applications of GIS: Disaster Management and Emergency Response

Geographic Information System (GIS) technology is essential for risk identification, action prioritization, and resource optimization in critical situations like flooding and earthquakes. By integrating spatial and demographic data, GIS provides a comprehensive framework for emergency response.GIS integrates data layers, like rainfall intensity, topography, elevation profiles, and river levels, to model high-risk flood zones. These layers assess areas susceptible to flooding based on their...
533
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.1K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
84.2K